Squarepoint’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.54M Buy
217,951
+150,963
+225% +$1.76M ﹤0.01% 1061
2025
Q1
$498K Buy
66,988
+22,587
+51% +$168K ﹤0.01% 1919
2024
Q4
$266K Buy
44,401
+32,247
+265% +$193K ﹤0.01% 2251
2024
Q3
$62.2K Buy
+12,154
New +$62.2K ﹤0.01% 2413
2024
Q1
Sell
-75,659
Closed -$371K 2392
2023
Q4
$371K Buy
+75,659
New +$371K ﹤0.01% 1860
2023
Q3
Sell
-31,637
Closed -$212K 2421
2023
Q2
$212K Buy
+31,637
New +$212K ﹤0.01% 2051
2023
Q1
Sell
-50,889
Closed -$389K 2221
2022
Q4
$389K Sell
50,889
-92,118
-64% -$704K ﹤0.01% 1576
2022
Q3
$1.02M Buy
+143,007
New +$1.02M 0.01% 1071
2022
Q2
Sell
-57,432
Closed -$797K 2078
2022
Q1
$797K Buy
+57,432
New +$797K ﹤0.01% 1241
2021
Q2
Sell
-41,956
Closed -$1.69M 2570
2021
Q1
$1.69M Buy
+41,956
New +$1.69M 0.01% 803
2019
Q4
Sell
-10,910
Closed -$337K 2353
2019
Q3
$337K Buy
+10,910
New +$337K ﹤0.01% 1760